7 results about "Triolein" patented technology

The invention provides a silicon nitride green body and a preparation method and application thereof.The silicon nitride green body comprises silicon nitride powder, a penetrating agent and a wetting agent, the penetrating agent comprises at least one of fatty alcohol-polyoxyethylene ether and nonylphenol polyoxyethylene ether, the wetting agent comprises at least one of glyceryl trioleate, glyceryl monooleate and polyoxyethylene ester, and the silicon nitride green body comprises silicon nitride powder, silicon nitride powder and silicon nitride powder. The total mass of the wetting agent and the penetrating agent is greater than or equal to 1% of the mass of the silicon nitride powder. Due to the special composition of the silicon nitride green body, the problems of warping, wrinkling and cracking can be effectively reduced while the high solid content is maintained.

The present invention relates to an impregnation liquid comprising diacetone alcohol in an amount of from 20% to 50% by weight; a glycerol trioleate in an amount of from 20% by weight to 50% by weight; castor oil in an amount of 10 wt% to 40 wt%; acetone in an amount of 3 wt% to 5 wt%; and at least one sulfonate or ester in an amount of from 0 wt% to 1.5 wt%. The invention also relates to a method for treating the surface of an iron component, comprising the step of impregnating with such an impregnating liquid; and the obtained treated component.

The invention discloses treprostinil multivesicular liposome for treating pulmonary arterial hypertension. The multivesicular liposome is prepared from an inner water phase, an oil phase and an outer water phase through a double emulsification method, the treprostinil is dissolved in the inner water phase; the oil phase comprises soybean lecithin, cholesterol, glyceryl trioleate and electronegative lipid; the inner water phase and the outer water phase are body fluid isotonic solutions. The treprostinil multivesicular liposome disclosed by the invention has good stability and high encapsulation efficiency, obviously reduces burst release effect, shows obvious slow release characteristic, is beneficial to prolonging in-vivo drug half-life period, and can realize 48-hour treatment, reduce administration frequency, simplify administration method and improve patient compliance through simple subcutaneous injection. After the treprostinil multivesicular liposome is injected once, the inflammatory reaction of the injection part can be eliminated within 7 days, and the treprostinil multivesicular liposome has good safety.

Anaplerotic Olebiome compositions comprising a blend of anaplerotic MOCL esters; a Triolein-enriched plant carrier oil, and at least one lipophilic antioxidant and / or antiaging ingredient are provided

The present invention belongs to the field of pharmaceutical technology, and relates to docetaxel triglyceride prodrugs and their lipid preparations, as well as docetaxel-triglyceride prodrugs mediated by lymphatic transport and their lipid preparations and their application in the preparation of oral chemotherapy drugs. The present invention provides a lipid preparation of docetaxel-triglyceride prodrug, which comprises a docetaxel-triglyceride prodrug and excipients. The excipients include phospholipid emulsifiers, short-chain alcohol or ether co-emulsifiers, and liquid oil phases. By weight percentage, the liquid oil phase accounts for 30%-85% of the lipid preparation, the phospholipid emulsifier accounts for 10%-45% of the lipid preparation, and the short-chain alcohol or ether co-emulsifier accounts for 5%-25% of the lipid preparation; the docetaxel-triglyceride prodrug accounts for 1%-10% of the total weight of the excipients. The docetaxel-triglyceride prodrug of the present invention promotes the lymphatic transport of docetaxel, avoids the first-pass effect, and thus improves its oral absorption.

Anaplerotic Olebiome compositions comprising a blend of anaplerotic MOCL esters; a Triolein-enriched plant carrier oil, and at least one lipophilic antioxidant and / or antiaging ingredient are provided.

The present invention relates to a stratum corneum retention improver including an ester of a component A that is ditrimethylolpropane, and a component B that is one or more fatty acids selected from saturated fatty acids having 6 to 12 carbon atoms. The present invention further relates to a shine-inhibiting agent including an ester of component A and component B, wherein the ester has a hydroxyl value of 140 mgKOH / g or less, and which inhibits shine caused by one or more oily components selected from the group consisting of squalene, triolein, macadamia seed oil, trimethylolpropane triisostearate, pentaerythrityl tetraisostearate, hydrogenated polyisobutene, hydrogenated polydecene, coco-caprylate / caprate, octyldodecyl myristate, and polyglyceryl-2 diisostearate.